Insights

For too long, MS-related brain fog and depression were dismissed as mere reactions to diagnosis. Now, revolutionary neuroimaging and holistic research prove these cognitive and emotional challenges are deeply rooted physical symptoms of the disease.

Cannes Lions proved creativity redefines healthcare communications. VML Health Global CCO, Jason Graff, shares his take on the winners and key lessons.

VML Health CEO Claire Gillis explores how GLP-1s could transform the medical landscape, echoing the cancer care revolution in expanding treatments options.

VML Health CEO Claire Gillis argues that this year’s Pharma Lions winners proved the value of confronting the health topics men would rather avoid.

VML Health’s Costas Saratsis and Disha Srivastava unpack how ASCO 2026 called on oncology to translate breakthrough science into real-world patient care.

Key downloads and clinical trends from the world of oncology.

With ASCO 2026 approaching, adaptive strategies are critical to shaping the future of oncology innovation in a rapidly evolving global landscape.

The market is moving fast. We combine deep insights into lived experiences with WPP Open's AI to navigate complexity and unlock access.

From the precision revolution to AI caregivers and systemic resilience, Health Futures delivers 10 trends to guide your strategy in the year ahead

On IWD, VML Health CEO Claire Gillis highlights why self-advocacy in women's health is vital and how women's voices drive change for all.

This International Day of Women & Girls in Science, Global CEO Claire Gillis reminds us why supporting women in science is key to closing the gender health gap.

Claire Gillis, CEO of VML Health, challenges us to look beyond World Cancer Day and recognize cancer as a daily reality for millions.

Cutting-edge science, from CAR-T to chemo-free therapies, now deeply intertwined with patient access & advocacy.

Breakthrough science and shifting market forces are rewriting what life sciences brands require from their agency partners.

2025 proved again that science delivers most when it’s anchored in relatable human insight.

A focus on patients and lived experience powered up in 2025, strengthening the path to faster, fairer access.